Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India. (25th July 2019)

• Record Type: Journal Article
• Authors: Pamidimukkala, Umabala; Sudhaharan, Sukanya; Kancharla, Anuradha; Vemu, Lakshmi; Challa, Sundaram; Karanam, Sandhya Devi; Chavali, Padmasri; Prakash, Hariprasath; Ghosh, Anup Kumar; Gupta, Sunita; Rudramurthy, Shivaprakash M; Chakrabarti, Arunaloke
• Is Part Of: Medical mycology. Volume 58:Number 4(2020)
• Page Start: 425
• Page End: 433
• Publication Date: 2019-07-25
• Subjects: Apophysomyces -- trauma -- Necrotizing fasciitis -- Mucorales -- immunocompetent; Medical mycology -- Periodicals; Veterinary mycology -- Periodicals; Mycology -- Periodicals; Mycoses -- Periodicals; Pathogenic fungi -- Periodicals; 616.969005
• DOI: 10.1093/mmy/myz081
• Languages: English
• ISSNs: 1369-3786

Abstract

Abstract: Apophysomyces elegans species complex is an important cause of cutaneous mucormycosis in India. However, majority of those cases are reported as case reports only. We desired to analyze our patients with Apophysomyces infection reported over 25 years (1992–2017) to understand the epidemiology, management, and outcome of the disease. During the study period 24 cases were reported, and the majority (95.8%) of them presented with necrotizing fasciitis following accidental/surgical/iatrogenic trauma. One patient presented with continuous ambulatory peritoneal dialysis (CAPD) related peritonitis. Healthcare related Apophysomyces infection was noted in 29.2% patients. In addition to trauma, comorbidities were noted in 37.5% patients (type 2diabetes mellitus-6, chronic alcoholism-2, and chronic kidney disease-1). Of the 24 isolates, 11 isolates starting from year 2014 were identified as Apophysomyces variabilis by molecular methods. Majority (95.8%) of the patients were managed surgically with or without amphotericin B deoxycholate therapy, while one patient was treated with amphotericin B deoxycholate alone. Among 24 patients, seven (29.1%) recovered, six (25%) patients could not afford antifungal management and left the hospital against medical advice, and 11 (45.9%) patients died.The present case series highlights that necrotizing fasciitis caused by A. variabilis is prevalent in India, and the disease may be healthcare related. Although diagnosis is not difficult, awareness among surgeons is still limited about the infection, leading to a delay in sending samples to the mycology laboratory. Apophysomyces infection must be considered in the differential diagnosis in apatient with progressive necrosis of a wound who is not responding to antibacterial therapy.